Neha S. Kargutkar
Mumbai, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
EIF2AK1 As a Key Genetic Determinant of Luspatercept Resistance in Transfusion-Dependent Thalassemia.
Journal: American journal of hematology
Published: April 22, 2026
Decoding HbF reactivation by hydroxyurea in hemoglobinopathy patients through microRNA signatures.
Journal: Annals of hematology
Published: December 07, 2024
Role of hydroxyurea therapy in the prevention of organ damage in sickle cell disease: a systematic review and meta-analysis.
Journal: Systematic reviews
Published: November 16, 2023
Effect of hydroxyurea on erythrocyte apoptosis in hemoglobinopathy patients.
Journal: Expert review of hematology
Published: July 03, 2023
When a synonymous mutation breaks the silence in a thalassaemia patient.
Journal: British journal of haematology
Published: May 16, 2023
Dynamic interplay of microRNA in diseases and therapeutic.
Journal: Clinical genetics
Published: July 21, 2022
Role of microRNA in hydroxyurea mediated HbF induction in sickle cell anaemia patients.
Journal: Scientific reports
Published: May 31, 2022
Diagnostic challenges posed by a rare unstable hemoglobin variant Hb Southampton [HBB: c.320T → C] with pyrimidine 5' nucleotidase deficiency and the response to HU therapy.
Journal: Blood cells, molecules & diseases
Published: February 15, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026